Call for applications Editors-in-Chief ESHRE journals
Applications for the position of Editors-in-Chief (EiC)* for "Human Reproduction" and for “Human Reproduction Update”
We are seeking new Editors-in-Chief for Human Reproduction and for Human Reproduction Update.
The appointment will be for a term of 3 years with the possibility of one renewable term of another 3 years thereafter.
The Editors-in-Chief will work closely together with the Editors-in-Chief of the other ESHRE Journals (i.e., “Molecular Human Reproduction” and “Human Reproduction Open”), the ESHRE Journals’ Editorial Office, the ESHRE Publications Committee, and the official publisher of the journals (Oxford University Press) to ensure that the highest scientific standards are maintained and promoted, in accordance with the journal’s aims and scope.
Applicants must be highly recognized in the broad field of reproductive biology/reproductive medicine. The successful applicant will have to give proof of vision and display a wide scope of knowledge consistent with overseeing the academic content. They should have experience of editorial processes and practice and must have clear views on how to promote the academic scientific quality of the journal.
* For Human Reproduction an alternative appointment of two, equal, Co-Editors-in-Chief may be considered by the selection Committee, dependent upon candidate suitability and preference. Each Co-Editor-in-Chief would contribute equally to the journal and work jointly towards setting and delivering an agreed editorial strategy. The Committee would therefore also welcome applications from individuals wishing to be considered for the position of Co-Editor-in-Chief. This should be declared in the letter of application.
A remuneration package including expenses will be agreed upon appointment and preliminary details can be obtained from the ESHRE Managing Director, Bruno Van den Eede.
For more information read the job adverts:
Applications should be sent to the ESHRE Central Office (bruno@eshre.eu) by 15 January 2024